Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
TROV [NASD]
TrovaGene, Inc.
Index- P/E- EPS (ttm)-0.92 Insider Own11.67% Shs Outstand24.46M Perf Week6.51%
Market Cap268.08M Forward P/E- EPS next Y-0.93 Insider Trans54.57% Shs Float22.03M Perf Month35.81%
Income-18.30M PEG- EPS next Q-0.24 Inst Own28.40% Short Float2.64% Perf Quarter93.98%
Sales0.30M P/S893.61 EPS this Y-8.60% Inst Trans83.99% Short Ratio1.37 Perf Half Y133.69%
Book/sh1.08 P/B10.15 EPS next Y13.10% ROA-51.20% Target Price10.25 Perf Year197.02%
Cash/sh1.80 P/C6.09 EPS next 5Y- ROE-119.50% 52W Range2.97 - 11.68 Perf YTD154.88%
Dividend- P/FCF- EPS past 5Y-9.20% ROI-63.90% 52W High-6.16% Beta-0.88
Dividend %- Quick Ratio8.40 Sales past 5Y-15.60% Gross Margin33.30% 52W Low269.02% ATR0.71
Employees31 Current Ratio8.40 Sales Q/Q0.00% Oper. Margin- RSI (14)64.49 Volatility5.96% 8.03%
OptionableYes Debt/Eq0.64 EPS Q/Q-94.10% Profit Margin- Rel Volume0.84 Prev Close11.00
ShortableYes LT Debt/Eq0.51 EarningsMay 05 AMC Payout- Avg Volume425.36K Price10.96
Recom1.80 SMA206.35% SMA5027.16% SMA20085.51% Volume358,264 Change-0.36%
Apr-20-15Reiterated Maxim Group Buy $10 → $13
Jul-10-14Initiated Maxim Group Buy $10
Nov-13-13Reiterated Aegis Capital Buy $14 → $10
Oct-01-13Reiterated Aegis Capital Buy $14
Jul-16-13Initiated Cantor Fitzgerald Buy $10
Apr-01-13Reiterated Aegis Capital Buy $12 → $14
Dec-12-12Initiated Aegis Capital Buy $12
May-28-15 08:43AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:05AM  Trovagene Launches Commercial Marketing Campaign at the 2015 American Society of Clinical Oncology Annual Meeting PR Newswire
May-19-15 09:20AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-13-15 05:21PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:01PM  Clinical Utility of Trovagene's Urine-Based Liquid Biopsy Platform to Be Highlighted at the American Society of Clinical Oncology Meeting PR Newswire
01:04PM  TROVAGENE, INC. Financials
May-12-15 09:46AM  TrovaGene (TROV) in Focus: Stock Rises 7.1% - Tale of the Tape
May-08-15 12:14PM  TrovaGene, Inc. Earnings Analysis: By the Numbers +5.39%
May-06-15 09:36AM  TrovaGene (TROV) Q1 Loss Wider than Expected, Shares Plunge - Analyst Blog +15.66%
May-05-15 06:44PM  Trovagene, Inc. Announces First Quarter 2015 Financial Results at noodls -5.28%
05:37PM  Trovagene reports 1Q loss
04:35PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:14PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report
04:01PM  Trovagene, Inc. Announces First Quarter 2015 Financial Results PR Newswire
07:07AM  Q1 2015 Trovagene Inc Earnings Release - 4:00 pm ET
May-04-15 10:04AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
09:23AM  Cost Benefit Analysis of Trovagene's Precision Cancer Monitoring Solution to Be Presented at the Association for Value-Based Cancer Care in Washington, DC at noodls
08:00AM  Cost Benefit Analysis of Trovagene's Precision Cancer Monitoring Solution to Be Presented at the Association for Value-Based Cancer Care in Washington, DC PR Newswire
May-01-15 11:55AM  Is it a Miss for TrovaGene (TROV) This Earnings Season? - Analyst Blog +9.81%
Apr-28-15 01:26PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:00AM  Trovagene Schedules Release of First Quarter 2015 Financial Results and Investor Conference Call PR Newswire
Apr-23-15 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:09AM  Trovagene's Urine-Based HPV Assay to Be Featured in Presentation at the 13th Annual Cervical Cancer Conference and HPV Consortium in Beijing at noodls
08:00AM  Trovagene's Urine-Based HPV Assay to Be Featured in Presentation at the 13th Annual Cervical Cancer Conference and HPV Consortium in Beijing PR Newswire
Apr-20-15 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
03:08PM  TrovaGene's (TROV) PCM Data Impresses, Shares Rally - Analyst Blog
08:21AM  Poster Presentations at 2015 AACR Annual Meeting to Highlight Clinical Utilities and Advantages of Trovagene's ctDNA Precision Cancer Monitoring Platform at noodls
08:00AM  Poster Presentations at 2015 AACR Annual Meeting to Highlight Clinical Utilities and Advantages of Trovagene's ctDNA Precision Cancer Monitoring Platform PR Newswire
Apr-17-15 10:45AM  Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients at noodls +20.14%
10:30AM  Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients PR Newswire
Apr-04-15 09:25AM  4 Fresh Biotech Stock Picks With Targets 50% to 100% Higher at 24/7 Wall St.
Mar-18-15 11:59AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
09:03AM  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer at noodls
08:31AM  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer PR Newswire
08:20AM  TrovaGene (TROV) Enters Overbought Territory - Tale of the Tape
Mar-17-15 08:37AM  TrovaGene (TROV) in Focus: Stock Adds 6.1% in Session - Tale of the Tape +8.30%
Mar-13-15 09:40AM  TrovaGene (TROV) Posts Wider Q4 Loss on Higher Expenses - Analyst Blog
Mar-12-15 07:04PM  Trovagene, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results at noodls
05:36PM  Trovagene reports 4Q loss
04:19PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:05PM  Trovagene, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results PR Newswire
Mar-10-15 04:52PM  What's in Store for TrovaGene (TROV) for Earnings Season? - Analyst Blog
Mar-03-15 12:16PM  TrovaGene Inc (TROV) Sees Bridger Management Buy More Shares; Other Stocks Roberto Mignone Loves at Insider Monkey +5.12%
Feb-26-15 05:51PM  Trovagene Schedules Release of Fourth Quarter and Year End 2014 Financial Results and Investor Conference Call at noodls +6.74%
04:05PM  Trovagene Schedules Release of Fourth Quarter and Year End 2014 Financial Results and Investor Conference Call PR Newswire
Feb-11-15 11:40AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11:11AM  Trovagene, Inc. Announces Closing of Public Offering of Common Stock at noodls
10:12AM  Trovagene, Inc. Announces Closing of Public Offering of Common Stock PR Newswire
Feb-10-15 08:05AM  Trovagene, Inc. to Present at Leerink Global Healthcare Conference PR Newswire +5.93%
Feb-09-15 12:46PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:05AM  Clinical Results Demonstrate High Sensitivity of Trovagene's Urine-Based HPV Assay for the Detection of High Risk HPV and Pre-Cancerous Cervical Lesions PR Newswire
Feb-06-15 02:46PM  TROVAGENE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online -23.59%
12:57PM  TrovaGene Falls Sharply; Prices Offering Below Expectations Benzinga
08:27AM  Trovagene, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire
Feb-05-15 04:17PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:09PM  Trovagene, Inc. Announces Public Offering of Common Stock PR Newswire
Jan-29-15 01:06PM  3 Biotech Stocks Under $10 in Breakout Territory: TrovaGene and More at TheStreet
Jan-26-15 12:00PM  TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog Zacks
11:55AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
08:35AM  Trovagene's Chief Scientific Officer to Present Precision Cancer Monitoring (SM) Platform Overview at the Personalized Medicine World Conference PR Newswire
Jan-21-15 08:21AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online -5.17%
03:01AM  Trovagene Expands Collaboration with Genomac to Demonstrate Clinical Utility in Lung and Colorectal Cancer Treatment Monitoring PR Newswire
Jan-20-15 12:02PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
08:15AM  Clinical Study Results Presented at the 2015 Gastrointestinal Cancer Symposium Support Utility of Trovagene's Precision Cancer Monitoring Platform in Colorectal and Pancreatic Cancer Patients PR Newswire
Jan-12-15 11:26AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
08:35AM  Trovagene Collaborates with UC San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients PR Newswire
Jan-08-15 09:32AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online +8.12%
08:00AM  Trovagene and City of Hope Collaborate To Monitor EGFR Mutational Status in Lung Cancer Patients PR Newswire
Jan-07-15 09:11AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online +6.54%
09:00AM  Trovagene to Present at the 7th Annual Biotech Showcase Conference PR Newswire
Jan-06-15 12:18PM  TROVAGENE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
06:00AM  Former President of BIO Joins Trovagene's Board of Directors PR Newswire
Dec-04-14 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online +5.26%
09:05AM  Trovagene Announces Presentation of Clinical Data at the 56th American Society of Hematology Annual Meeting PR Newswire
Nov-26-14 09:05AM  Trovagene to Present at 26th Annual Piper Jaffray Healthcare Conference PR Newswire -5.12%
Nov-21-14 04:35PM  TrovaGene Cancer Technology Detects KRAS Mutation Zacks
Nov-20-14 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online +8.31%
09:08AM  Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients PR Newswire
Nov-12-14 08:15AM  Trovagene to Present at Upcoming Healthcare Conferences PR Newswire
Nov-06-14 04:13PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:05PM  Trovagene, Inc. Announces Third Quarter 2014 Financial Results PR Newswire
04:03PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q3 2014 Trovagene Inc Earnings Release - 4:00 pm ET CCBN
Nov-05-14 02:40PM  What's in Store for TrovaGene (TROV) This Earnings Season? Zacks
Oct-29-14 08:10AM  Trovagene Schedules Release of Third Quarter 2014 Financial Results and Investor Conference Call PR Newswire
Oct-27-14 08:10AM  Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery PR Newswire
Oct-06-14 04:30PM  Trovagene to Present at 13th Annual BIO Investor Forum PR Newswire
Oct-03-14 06:00AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online +8.14%
Oct-01-14 08:05AM  Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium PR Newswire -5.90%
Sep-29-14 08:05AM  Trovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer PR Newswire +5.12%
Sep-18-14 04:00PM  TROVAGENE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Sep-17-14 08:05AM  Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
Sep-15-14 07:50AM  Can The Uptrend Continue for TrovaGene (TROV)? Zacks
Sep-08-14 06:49AM  Increased Earnings Estimates Seen for TrovaGene (TROV): Can It Move Higher? Zacks
Sep-04-14 06:59AM  How TrovaGene (TROV) Stock Stands Out in a Strong Industry Zacks
Aug-26-14 08:24AM  Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics PR Newswire
07:07AM  TrovaGene (TROV) Jumps: Stock Rises 9.2% Zacks
Aug-25-14 08:05AM  Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay. PR Newswire +9.18%
Aug-22-14 07:33AM  Can the Rally in TrovaGene (TROV) Shares Continue? Zacks
Aug-20-14 04:47PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. The company intends to enhance the treatment outcomes for cancer patients through its proprietary technology to detect and quantitatively monitor cell-free DNA using urine or blood samples. It is developing PCM BRAF and KRAS mutation detection tests for detecting mutations in metastatic cancer patients; and HPV HR detection test to detect the presence of various HPV genotypes using a urine sample. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRIDGER MANAGEMENT, LLC10% OwnerApr 02Buy6.90300,0002,070,0003,150,587Apr 06 05:00 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 27Buy5.6279,343445,9082,850,587Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 26Buy5.4278,801427,1012,771,244Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 25Buy5.12105,142538,3272,692,443Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 06Buy4.50444,4441,999,9982,587,301Feb 10 04:25 PM
ZANIBONI STEVECFOJun 09Buy3.956,32925,0006,329Jun 10 03:59 PM